Shares of Bioton SA, Poland's first biotechnology stock to go public, begun trading at 3.27 zloty yesterday despite massive sell-off on the Warsaw stock exchange. Earlier this month maker of recombination human insulin sold 16 million shares at 2.75 zloty each.
Bioton co-founder, Polish businessman Ryszard Krauze, said the company will aim to increase its global market share to 5 percent within two to three years, boosting sales to 1.5 billion zloty.
Insurance
PZU reports 2004 earnings
Powszechny Zakład Ubezpieczeniowy, Poland's biggest insurance group, said its profits surged 61 percent last year, boosted by an increase in premiums made possible by the expanding Polish economy and higher living standards. Net income jumped to PLN 2.19 billion ($720 million), chief executive Cezary Stypułkowski, a former Citigroup manager in Poland said. Overall premiums were up 5 percent to as much as 12.9 billion zloty, Warsaw-based insurer said.
PZU also said it plans to pay half of last year's earnings as dividends. PZU itself, without its life insurance unit and other subsidiaries, reported earnings of 1.41 billion zloty.